tiprankstipranks
Pharmaxis Ltd (AU:SNT)
ASX:SNT
Australian Market

Pharmaxis Ltd (SNT) Financial Statements

Compare
10 Followers

Pharmaxis Ltd Financial Overview

Pharmaxis Ltd's market cap is currently AU$141.23M. The company's EPS TTM is AU$-0.021; its P/E ratio is ―; Pharmaxis Ltd is scheduled to report earnings on February 7, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement
Total Revenue
Gross Profit$ 7.43M$ 6.68M$ 7.03M$ 5.68M$ 7.28M
Operating Income$ -22.77M$ -20.64M$ -21.47M$ -25.88M$ -26.35M
EBITDA$ -12.15M$ 551.00K$ -18.23M$ -17.20M$ 10.33M
Net Income$ -1.94M$ -2.97M$ -13.94M$ -20.06M$ 6.43M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 25.19M$ 33.59M$ 35.42M$ 52.67M$ 50.10M
Total Debt$ 4.29M$ 6.32M$ 8.15M$ 7.17M$ 8.27M
Net Debt$ -4.65M$ -12.39M$ -6.61M$ -23.95M$ -22.80M
Total Liabilities$ 14.38M$ 30.75M$ 33.98M$ 37.85M$ 38.98M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -16.41M$ 2.42M$ -13.86M$ -20.78M$ 11.32M
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Currency in USD

Pharmaxis Ltd Earnings and Revenue History

Pharmaxis Ltd Debt to Assets

Pharmaxis Ltd Cash Flow

Pharmaxis Ltd Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis